MHRA AdvanceGxP service: building compliance into innovation earlier

Imported from official source

Alert

Safety Classified by Officially

AdvanceGxP is a new MHRA service being developed to help organisations working on novel medicines technologies consider Good Practice requirements earlier, reducing regulatory uncertainty while maintaining independent regulatory and inspection decision-making.

Developed with the Office for Life Sciences, AdvanceGxP will initially focus on disruptive innovation in medicines manufacturing. As the service develops, it will explore how earlier, practical and principles-based regulatory support can help innovators make better-informed decisions before critical development, manufacturing and investment choices are fixed.

Innovation in medicines and advanced manufacturing is moving quickly. For organisations developing emerging technologies, there may be limited precedent, detailed guidance or case studies showing how established Good Practice principles will apply. This can create uncertainty at precisely the point when important decisions about facilities, processes, validation and investment are being made.

AdvanceGxP is being developed to help close that gap

By bringing regulatory and compliance thinking into development earlier, AdvanceGxP aims to help organisations understand relevant Good Practice principles, identify potential issues and build compliance into innovation from the outset. This can help organisations make better-informed decisions and manage regulatory and compliance risks within their own development programmes.

Earlier access to practical Good Practice expertise

When fully operational, AdvanceGxP will provide earlier access to practical, regulator-led Good Practice expertise for organisations developing novel and potentially disruptive medicines technologies. The service is being designed to:

  • help organisations explore how Good Practice principles may apply to emerging technologies
  • support earlier consideration of compliance, before key development decisions are fixed
  • provide practical regulatory and compliance insight
  • This is an extract. The publication continues at the source.

    Contains public sector information licensed under the Open Government Licence v3.0. Licence

    Read the original at the source: https://www.gov.uk/guidance/mhra-advancegxp-service-building-compliance-into-innovation-earlier

    Officially imported this from Medicines and Healthcare products Regulatory Agency’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

    Provenance

    Organization
    Medicines and Healthcare products Regulatory Agency — imported from official source
    Official source
    https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency.atom ATOM
    Imported
    November 18, 2026 10:00
    Versions
    1 recorded
    Identity
    https://www.gov.uk/guidance/mhra-advancegxp-service-building-compliance-into-innovation...

    Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.